Codexis, Inc. (CDXS)
-NasdaqGS 2.61 
0.05(1.88%) 4:00PM EDT
| Prev Close: | 2.66 |
|---|
| Open: | 2.66 |
|---|
| Bid: | 2.51 x 1000 |
|---|
| Ask: | 2.85 x 1000 |
|---|
| 1y Target Est: | 3.75 |
|---|
| Beta: | 1.89 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.47 - 2.69 |
|---|
| 52wk Range: | 1.99 - 4.00 |
|---|
| Volume: | 258,593 |
|---|
| Avg Vol (3m): | 150,530 |
|---|
| Market Cap: | 99.25M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.89 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Gevo Begins Countdown to Ethanol's Endat Motley Fool(Tue 2:44PM EDT)
- Movers roundup: Synergy Pharma, CodexisAP(Fri, Jun 14)
- Codexis climbs on Chemtex production milestoneAP(Fri, Jun 14)
- Codexis and Chemtex Achieve Key Milestone in Commercial Development of Bio-Based Chemicals from Non-Food Cellulosic BiomassBusiness Wire(Fri, Jun 14)
- Grainger's May Sales Rise 5%Zacks(Wed, Jun 12)
- World's Largest Chemical Company Makes a Splash in Enzymesat Motley Fool(Fri, Jun 7)
- Codexis Appoints Scott Watson as Vice President of Sales and MarketingBusiness Wire(Tue, Jun 4)
- Has This New Biotech Industry Learned Its Lesson?at Motley Fool(Thu, May 30)
- Codexis' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Mon, May 20)
- 5 Best Stocks to Invest in Industrial Biotechat Motley Fool(Sat, May 18)
- CODEXIS INC FinancialsEDGAR Online Financials(Fri, May 17)
- CODEXIS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, May 16)
- Codexis to Present at 2013 UBS Global Healthcare ConferenceBusiness Wire(Tue, May 14)
- Earnings Volatility Drives These Stocks in a New Directionat Wall St. Cheat Sheet(Sun, May 12)
- CODEXIS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.47 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.30 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | -0.22 |
|---|
Business Summary
Codexis, Inc. engages in the production of custom industrial enzymes for use in the pharmaceutical, biofuel, and chemical production. The company offers Codex Biocatalyst Panels and Kits to pharmaceutical companies that are engaged in drug develop...
View More